Avoro Capital Advisors LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$29,929,000
-44.3%
935,000
-38.7%
0.52%
-43.8%
Q1 2021$53,695,000
+9.8%
1,525,0000.0%0.93%
+10.1%
Q4 2020$48,907,000
-13.3%
1,525,000
+1.7%
0.84%
+5.0%
Q3 2020$56,430,000
-11.5%
1,500,000
+5.3%
0.80%
-36.4%
Q2 2020$63,769,000
+62.6%
1,425,000
+23.9%
1.26%
-4.8%
Q1 2020$39,227,0001,150,0001.32%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders